691 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Tallman
    Tallman
  5. Zelenetz
    Zelenetz
  6. Moskowitz
    Moskowitz
  7. Berman
    Berman
  8. Steinherz
    Steinherz
  9. Andreeff
    Andreeff
  10. Horwitz
    Horwitz

Groups

  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)
  7. Lymphoma (86)
  8. Sloan Kettering Institute Faculty (82)
  9. GSK Faculty (75)
  10. Pediatrics, Department of (75)
  1. "cytarabine"
Formats
  1. Journal Article (637)
  2. Review (20)
  3. Conference Paper (19)
  4. Research Letter (6)
  5. Correspondence (3)
  6. Editorial (2)
  7. Meeting Abstract (2)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (359)
  2. Center for Hematologic Malignancies (304)
  3. Hematologic Malignancies, Division of (301)
  4. Adult Leukemia (134)
  5. Tow Center for Developmental Oncology (TCDO) (103)
  6. Survivorship Research (102)

More Groups

People
  1. Lisa De Angelis (53)
  2. Martin Tallman (42)
  3. Joachim Yahalom (39)
  4. Lauren Abrey (38)
  5. Peter Steinherz (34)
  6. Andrew Zelenetz (33)

More People

Years
  1. 2025 (15)
  2. 2024 (28)
  3. 2023 (17)
  4. 2022 (11)
  5. 2021 (9)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (45)
  2. Blood (41)
  3. Cancer (29)
  4. Leukemia (27)
  5. Bone Marrow Transplantation (25)
  6. Leukemia and Lymphoma (23)

More Publications

Publishers
  1. Elsevier Inc. (102)
  2. Nature Publishing Group (67)
  3. American Society of Hematology (52)
  4. Springer (52)
  5. American Society of Clinical Oncology (48)
  6. Lippincott Williams & Wilkins (38)

More Publishers

Results (691)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute leukemia with predominantly myeloid differentiation and TBL1XR1::CSF1R fusion
    Miscellaneous

    Kumar, J.; Petrova-Drus, K.
    Blood (2023)

    Fulltext@MSK | Save
  • Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma
    Journal Article

    Villa, D.; Jiang, A.; Visco, C.; Crosbie, N.; McCulloch, R.; Buege, M. J.; Kumar, A.; Bond, D. A.; Paludo, J.; Maurer, M. J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses
    Journal Article

    Maximova, O. A.; Weller, M. L.; Krogmann, T.; Sturdevant, D. E.; Ricklefs, S.; Virtaneva, K.; Martens, C.; Wollenberg, K.; Minai, M.; Moore, I. N.; more...
    PLoS Pathogens (2023)

    Fulltext@MSK | Save
  • Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
    Journal Article

    Foran, J. M.; Sun, Z.; Lai, C.; Fernandez, H. F.; Cripe, L. D.; Ketterling, R. P.; Racevskis, J.; Luger, S. M.; Paietta, E.; Lazarus, H. M.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia
    Journal Article

    Atchley, E.; Weis, T. M.; Derkach, A.; Galera, P. K.; Xiao, W.; Glass, J.; DeWolf, S.; Roshal, M.; Shah, R.; Stump, S. E.
    Leukemia Research (2023)

    Fulltext@MSK | Save
  • What’s next after hypomethylating agents failure in myeloid neoplasms? A rational approach
    Review

    Awada, H.; Gurnari, C.; Xie, Z.; Bewersdorf, J. P.; Zeidan, A. M.
    Cancers (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
    Research Letter

    Przespolewski, A.; Goldberg, A. D.; Talati, C.; Fazal, S.; Vachhani, P.; Sanikommu, S. R.; Thota, S.; Waksal, J.; Ball, B.; Famulare, C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • High-dose cytarabine and autologous stem-cell transplantation in mantle cell lymphoma: Long-term follow-up of the randomized Mantle Cell Lymphoma Younger trial of the European Mantle Cell Lymphoma Network
    Journal Article

    Hermine, O.; Jiang, L.; Walewski, J.; Bosly, A.; Thieblemont, C.; Szymczyk, M.; Pott, C.; Salles, G.; Feugier, P.; Hübel, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save